TY  - JOUR

T1  - EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer

JO  - Breast Cancer Research and Treatment

PY  - 2000/05/31

AU  - Hamilton A

AU  - Roy J-A

AU  - Beex L

AU  - Piccart M

AU  - Mauriac L

AU  - Coleman R

AU  - Paridaens R

AU  - Boes GH

AU  - van Vreckem A

AU  - Palmer P

AU  - Klijn J

ED  - 

DO  - DOI: 10.1023/a:1006398518037

PB  - Springer Science and Business Media LLC

VL  - 60

IS  - 2

SP  - 181

EP  - 188

Y2  - 2025/10/10

ER  -